Stroke and Body Temperature Regulation After an Attack

Stroke damages the brain’s ability to regulate body temperature, and roughly half of all hospitalized stroke patients develop fever in the days that follow. That fever is not just a symptom to manage; it actively worsens brain injury. A comprehensive meta-analysis found that fever after stroke or neurological injury was associated with a relative risk of death about one and a half times higher than in patients who stayed afebrile, and the association extended to every measure of disability researchers examined. What makes post-stroke temperature dysregulation so clinically urgent is its complexity: the fever can come from infection, from direct brain damage, or from both, and the timing, direction, and cause of the temperature shift all change what it means for recovery.

How the Brain Controls Temperature and What Stroke Does to That System

Your body’s thermostat sits in a small region of the brain called the hypothalamus, specifically in the preoptic area and anterior nuclei. These clusters of neurons sense blood temperature and send signals down through the brainstem and into the sympathetic nervous system, adjusting heat production and heat loss to keep your core temperature remarkably stable. When those neurons detect warmth, they dial down heat-generating processes; when they detect cooling, they ramp up mechanisms like shivering and activation of metabolically active fat tissue.

A stroke can disrupt this system in two ways. If the stroke directly damages the hypothalamus, the brainstem pathways that carry temperature-regulating signals, or the frontotemporal regions that communicate with these areas, the thermostat itself breaks. The brain loses its ability to sense or respond to temperature changes properly. The signaling pathway involves a cascade of inhibitory neurotransmitters, and when a hemorrhage or infarct interrupts that chain, temperature can climb unchecked because the normal “off switch” for heat production no longer functions.¹ Even when the hypothalamus itself is spared, the inflammatory response triggered by dying brain tissue can push body temperature upward. And of course, stroke patients are often immobilized, catheterized, and mechanically ventilated, all of which increase infection risk and create a second, separate pathway to fever.

How Common Fever Is and When It Peaks

About half of patients hospitalized for stroke develop fever, a figure that has held steady across multiple studies spanning decades.² The typical pattern is a rise in body temperature beginning four to six hours after stroke onset, peaking around 48 hours, and remaining a concern through the first 72 hours.³ One study found that during those first 72 hours, about 61% of their stroke cohort experienced at least one episode of elevated temperature, with an infectious cause identified in just over half of those cases.⁴ Research also shows that fever occurs at similar rates regardless of whether the stroke was caused by a blood clot blocking an artery or by bleeding into the brain.⁵

The temperature rise associated with more severe strokes tends to be more pronounced. Patients with mild or moderate strokes sometimes show no measurable fever at all, while those with major strokes and impaired consciousness are far more likely to develop sustained high temperatures. This relationship between stroke severity and fever intensity creates a frustrating clinical puzzle: the patients who are already in the most danger are the ones whose temperature regulation is most disrupted.

Why Fever in the First 24 Hours Is Especially Damaging

Not all post-stroke fever carries the same risk. The same study that tracked fever in the first 72 hours found a striking difference based on timing. When elevated temperature appeared within the first 24 hours of stroke onset, it was independently linked to roughly three times the odds of a larger area of brain damage, three times the odds of worse neurological deficits at three months, and about three and a half times the odds of dependency at three months. Fever that started after the 24-hour mark did not show the same independent association with worse outcomes.⁴

The likely explanation involves what is happening in the brain during those early hours. In an ischemic stroke, there is a core of tissue that dies almost immediately and a surrounding “penumbra” of brain cells that are injured but potentially salvageable. Higher temperature speeds up destructive metabolic processes in that vulnerable zone, increasing the release of toxic chemicals, accelerating cell death, and widening the area of permanent damage. Once the penumbra has either been rescued or lost, the window during which fever can worsen the final infarct size narrows considerably.

A broad meta-analysis put the overall picture into sharper focus. Across studies of stroke and other neurological injuries, fever was associated with worse outcomes on every scale researchers measured. The relative risks ranged from about 1.3 for gross neurological status to 2.2 for functional disability, and patients with fever spent roughly three times as long in the hospital.⁶

Central Fever Versus Infectious Fever

One of the most important clinical distinctions after stroke is whether the fever is coming from infection or from the brain injury itself. Central fever, sometimes called neurogenic fever, results from direct damage to temperature-regulating brain structures. Infectious fever comes from the expected culprits: pneumonia, urinary tract infections, bloodstream infections. The treatments are different, and getting the diagnosis wrong wastes time and resources in a situation where every hour matters.

In a study of patients in a neurologic intensive care unit, fever was classified as central in about 47% of cases. Central fever tended to appear earlier, with over three-quarters of cases starting within 72 hours of admission, compared to about 61% of infectious fevers. Central fever was also more likely to be persistent, lasting longer than six hours for two or more consecutive days. Certain diagnoses predicted central fever: patients with subarachnoid hemorrhage, intraventricular hemorrhage, or brain tumors were more than six times as likely to have central rather than infectious fever. When clinicians combined the presence of negative cultures, clear chest imaging, one of those diagnoses, and fever onset within 72 hours, they could predict central fever with about 90% probability.⁷

Blood markers help too. Infectious fever tends to show elevated inflammatory markers like C-reactive protein, procalcitonin, and white blood cell counts, while central fever does not produce these same spikes.⁸ This matters because central fever does not respond to antibiotics, and giving unnecessary antibiotics breeds resistant organisms. Central fever also responds poorly to standard antipyretic drugs like acetaminophen, since the fever is not being driven by the usual inflammatory signaling that those drugs interrupt. Recognizing central fever early allows clinicians to pivot toward physical cooling methods or other targeted interventions rather than cycling through antibiotics searching for an infection that does not exist.

Different Stroke Types, Different Damage Pathways

Fever worsens outcomes in both ischemic strokes (caused by clots) and hemorrhagic strokes (caused by bleeding), but the underlying biology differs. In ischemic stroke patients who developed elevated temperatures, researchers found higher levels of glutamate, a neurotransmitter that in excess becomes toxic to brain cells. The harmful effect of fever in these patients appeared to be driven by this glutamate surge and the resulting expansion of the infarct volume. In hemorrhagic stroke patients with fever, the story was different: elevated temperature was linked to higher levels of an enzyme called active MMP-9, which breaks down the structural proteins holding brain tissue together, worsening bleeding and swelling. The clinical endpoint was similar in both groups, poor functional outcomes, but the mechanisms driving the damage were largely distinct.⁹

This distinction has real implications for treatment research. A drug that targets glutamate toxicity might protect ischemic stroke patients from fever-related damage but do nothing for hemorrhagic patients, and vice versa. It also means that blanket protocols for “post-stroke fever” may eventually be replaced by approaches tailored to stroke type, though clinical practice has not yet reached that level of specificity.

Circadian Rhythm Disruption After Stroke

Healthy people follow a predictable daily temperature pattern, with a slight dip in the early morning hours and a gentle rise through the afternoon and evening. After a moderate to severe stroke, this rhythm can flatten out or disappear entirely. One study of acute stroke patients found that their temperature fluctuations across the day no longer followed a recognizable circadian pattern.¹⁰ The disruption tends to be worse in more severe strokes and most pronounced in patients with disorders of consciousness, where the normal daily temperature rhythm can be completely absent.³

This matters for prognosis. Researchers have found that the degree of circadian rhythm disruption, measured both by temperature patterns and by wrist movement sensors, correlates with functional outcomes at three months, independent of how severe the initial stroke was. In other words, if your body’s daily rhythms recover, that is itself a sign that your brain is healing. And the time of day a stroke occurs interacts with temperature in surprising ways. Patients who suffered strokes between midnight and 8:00 a.m. had a stronger association between elevated admission temperature and mortality than patients whose strokes occurred during daytime hours, even though overall body temperatures tend to be lower during those nighttime hours.¹¹ The implication is that an elevated temperature during a period when the body should naturally be cool is a more ominous signal than the same temperature during the afternoon, when it could partly reflect normal circadian variation.

When Temperature Drops Too Low

Most of the clinical focus is on fever, but spontaneous hypothermia at admission, a core temperature below about 36°C, is even more dangerous in some ways. A large multicenter study of nearly 13,600 brain injury patients, including nearly 3,000 with ischemic stroke and over 4,000 with hemorrhagic stroke, found that hypothermia at admission was especially common in hemorrhagic stroke patients. The in-hospital death rate among those who arrived hypothermic was dramatically higher: after adjusting for other risk factors, admission hypothermia was associated with nearly eight times the odds of dying in the hospital, compared to about 1.3 times the odds for patients who arrived with fever.¹²

Why would low temperature be so much worse? Some researchers believe that a spontaneously low body temperature early after stroke reflects a more catastrophic loss of brain function. The thermoregulatory system has essentially shut down rather than just misfiring. There is also evidence that lower temperatures in the very early hours may impair the body’s ability to dissolve clots, potentially making ischemic strokes worse before treatment can begin. Paradoxically, this is the opposite of what happens with deliberate, controlled therapeutic cooling, which is applied under carefully monitored conditions and targets different time windows and temperature ranges.

Managing Temperature After Stroke

Given the strong link between fever and poor outcomes, you might expect aggressive temperature control to be standard practice. The reality is more complicated. A randomized trial of acetaminophen in acute ischemic stroke found that a high dose (6 grams per day) lowered body temperature by about 0.4°C compared to placebo at 24 hours. But a standard dose did not produce a measurable temperature reduction, and even the high-dose benefit had disappeared by day five.¹³ For central fever, which does not involve the inflammatory pathways that antipyretics target, medications are even less effective.

This has pushed the field toward targeted temperature management, an approach that uses external or internal cooling devices to control core body temperature precisely. Surface cooling systems circulate chilled water through pads or blankets placed on the skin. More aggressive approaches involve threading a catheter through the femoral vein into a major blood vessel and running blood past a cooling element, which can control temperature with greater speed and precision. Both approaches can be combined with temperature-feedback systems that automatically adjust cooling intensity.¹⁴ Preclinical research has been enthusiastic about therapeutic cooling, showing that it acts on multiple damage pathways simultaneously and can protect brain tissue when applied under the right conditions.¹⁵

But translating this into reliable clinical benefit has proved harder than the animal studies suggested. Cooling a conscious stroke patient is not the same as cooling an anesthetized laboratory animal. And the intervention carries its own risks: in one early trial of moderate hypothermia for severe middle cerebral artery strokes, 40% of cooled patients developed pneumonia.¹⁶ Despite decades of promising preclinical data, the clinical evidence remains mixed, and the ideal target temperature, duration, and patient selection for therapeutic cooling after stroke have not been definitively established.

The Shivering Problem

One of the biggest practical obstacles to cooling stroke patients is shivering. When you lower someone’s body temperature, their thermoregulatory system fights back. In stroke patients, vasoconstriction and shivering kick in at roughly normal temperature thresholds, meaning the body’s defenses against cooling activate before you have achieved any meaningful temperature reduction. Early research found that these responses effectively prevented induction of therapeutic hypothermia via surface cooling alone.¹⁷

Shivering is more than just uncomfortable. It generates heat, directly counteracting the cooling effort. It increases metabolic demand and oxygen consumption at a time when the brain can least afford either. And it raises intracranial pressure. Managing shivering has become a specialized clinical challenge. Current best practices recommend a tiered, preemptive approach: give an antipyretic like acetaminophen around the clock, administer buspirone on a standing schedule, infuse magnesium sulfate to raise serum levels above the normal range, and apply skin counterwarming with a heated blanket set no higher than 43°C. This last tactic sounds counterintuitive, warming the skin while cooling the core, but it works by tricking peripheral temperature sensors into reporting warmth, which suppresses the shivering reflex without interfering with core cooling. If shivering breaks through despite these measures, clinicians escalate to stronger sedatives or, in severe cases, neuromuscular blockade.¹⁸

Continuous Monitoring and Its Challenges

Catching dangerous temperature shifts early requires frequent or continuous monitoring, but measuring core body temperature accurately is harder than it sounds, especially in a stroke ward. The gold standard methods, such as bladder or esophageal probes, are invasive and impractical for many patients. Tympanic (ear) thermometers are commonly used but can be affected by positioning and technique. Newer non-invasive devices that measure heat flux from the skin and calculate core temperature from the gradient have shown promise. One validation study in acute ischemic stroke patients found that a wireless heat-flux thermometer closely tracked tympanic readings, correctly identifying hyperthermia in about 94% of cases and fever in over 97%.¹⁹

Continuous monitoring matters because post-stroke temperature does not behave predictably. As the circadian rhythm data show, the normal daily fluctuation that would help clinicians anticipate peaks and troughs may be absent or inverted. A single spot check might catch a patient at their lowest temperature of the day and miss a dangerous spike two hours later. Wearable, continuous sensors could fill that gap, alerting staff the moment temperature drifts outside a safe range. The technology exists and performs well in testing; the challenge now is integrating it into clinical workflows so that the information actually reaches the right people at the right time, and this remains an active area of development in stroke care.